IRONWOOD PHARMACEUTICALS, INC. (IRWD) Total liabilities 2016–2025
IRONWOOD PHARMACEUTICALS, INC. (IRWD) total liabilities at each fiscal year-end, per SEC filings.
$658.7MFY2025 · since FY2016: $643.1M → $658.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $658.7M | +1.0% |
| FY2024 | $652.2M | -20.2% |
| FY2023 | $817.4M | +82.4% |
| FY2022 | $448.1M | -14.0% |
| FY2021 | $521.0M | +4.9% |
| FY2020 | $496.6M | +0.1% |
| FY2019 | $496.0M | -6.1% |
| FY2018 | $528.4M | -11.3% |
| FY2017 | $595.8M | -7.4% |
| FY2016 | $643.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRWD financial trends
IRWD RevenueIRWD Net incomeIRWD Net marginIRWD Gross profitIRWD Gross marginIRWD Operating incomeIRWD Operating marginIRWD Operating cash flowIRWD Free cash flowIRWD Capital expendituresIRWD Return on equityIRWD Stock buybacksIRWD Dividends paidIRWD Total assetsIRWD Shareholders’ equityIRWD overview →